Home > News > Heiner Dreismann Joins Nanogen Board
October 31st, 2006
Heiner Dreismann Joins Nanogen Board
Nanogen, Inc. (Nasdaq:NGEN), developer of advanced diagnostic products, announced today that
Heiner Dreismann, Ph.D. has been named to its Board of Directors.
Dreismann, currently CEO of FasTraQ, Inc., has more than 20 years
experience with Roche in the biotech and healthcare industry, most recently
as president and CEO of Roche Molecular Systems.
Device to control 'color' of electrons in graphene provides path to future electronics August 31st, 2016
Graphene key to growing 2-dimensional semiconductor with extraordinary properties August 30th, 2016
University of Akron researchers find thin layers of water can become ice-like at room temperature: Results could lead to an assortment of anti-friction solutions August 30th, 2016
Nanocatalysis for organic chemistry: This research article by Dr. Qien Xu et al. is published in Current Organic Chemistry, Volume 20, Issue 19, 2016 August 30th, 2016
Dr Barbara Armbruster joins XEI Scientific as Marketing Director June 1st, 2016
Park Systems Global Expansion in AFM Market Includes Appointment of New Executives April 23rd, 2016
GLOBALFOUNDRIES Adds Alain Mutricy as Head of Product Management Group March 3rd, 2016
George Clark Named Chief Financial Officer and Associate Laboratory Director for Business Services at Brookhaven Lab February 24th, 2016